Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
11/2010
11/09/2010US7829565 such as 5-{4-[4-(5-cyano-2,3-dihydro-1H-indol-3-yl)butyl]piperazin-1-yl}benzo-furan-2-carboxamide, used as antidepressant, anxiolytic, neuroleptic and/or hyportensive agents and for treating headaches, tardive dyskinesia, obsessive compulsive, sleep, eating, sexual and/or learning disorders
11/09/2010CA2434937C Phenyl derivatives
11/04/2010WO2010126034A1 Novel compound, histone acetylase inhibitor, nuclear receptor transcription activation inhibitor, deuteromycetes belonging to genus penicillium, and production process
11/04/2010WO2010126006A1 Photosensitive resin composition, photosensitive element utilizing the composition, method for formation of resist pattern, and process for production of printed circuit board
11/04/2010WO2010125134A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125103A1 Diketopiperazine derivatives as p2x7 modulators
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010US20100280188 4-hydroxyphenylalkylamine derivative
11/04/2010US20100280028 Cxcr3 receptor antagonists
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100279997 Analgesic that binds filamin a
11/04/2010US20100279871 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100277060 Electroluminescent device
11/04/2010CA2759482A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/03/2010EP2246336A1 Fibrosis inhibitor
11/03/2010EP1487795B1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
11/03/2010CN101878553A Light-emitting element, light-emitting device, and electronic device
11/03/2010CN101875642A Synthetic method of 4-(6-chloroquinoxalin-2-yloxy) phenol
11/03/2010CN101875641A Synthetic method of 2,3-pyrazinedicarboxylic acid
11/03/2010CN101875640A Method for preparing pyrazinecarboxylic acid in ionic liquid
11/03/2010CN101874798A Difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase and application thereof
11/03/2010CN101433824B Method for extracting sulfabenzpyrazine from animal sample and special immune affinity sorbent thereof
11/03/2010CN101323599B Chemical synthesis method for 2-formylcyanoacetylhydrazone-quinoxaline-1,4-dioxide
11/03/2010CN101318937B Alkaloid compounds, preparation method and application thereof
11/02/2010US7825278 Central nervous system disorders; gamma aminobutyric acid (GABA) receptor complex modulators
11/02/2010US7825247 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/02/2010US7825120 tert-butyl 4-{[3-({[(6-methyl-3-pyridyl)amino]carbonylamino}methyl)phenyl]methyl}-piperazinecarboxylate; selectively modulates the cardiac sarcomere, for example by potentiating cardiac myosin, and may be useful in the treatment of systolic heart failure including congestive heart failure
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123956A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010WO2010123806A1 Synthesis of pyrazines including 2,6-diaminopyrazine-1-oxide (dapo) and 2,6-diamino-3,5-dinitropyrazine-1-oxide (llm-105)
10/28/2010WO2010123792A1 Preparation of c-pyrazine-methylamines
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122794A1 Process for production of pyrazinecarboxylic acid derivative, and intermediate for the production
10/28/2010WO2010122793A1 Process for production of pyrazine derivative, and intermediate for the production
10/28/2010WO2010122082A1 Heterocyclic antiviral compounds
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100274011 Method for the production of an amine
10/28/2010US20100273813 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
10/28/2010US20100273803 Oral Formulations for Tetrapyrrole Derivatives
10/28/2010US20100273795 Arylsulfonamide ccr3 antagonists
10/28/2010US20100273785 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/28/2010CA2758985A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758968A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758838A1 Heterocyclic antiviral compounds
10/28/2010CA2752826A1 Preparation of c-pyrazine-methylamines
10/27/2010EP1789044B1 Phenylaminopyridines and phenylaminopyrazines
10/27/2010EP1786784B1 Catalysis of diketopiperazine synthesis
10/27/2010CN101874021A Azaindenofluorenedione derivative, organic electroluminescent device material, and organic electroluminescent device
10/27/2010CN101869824A Flue gas desulfurizing agent and flue gas desulfurization method
10/26/2010US7820838 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
10/26/2010US7820817 substituted piperazine compounds that are useful modulators of muscarinic receptors; 1-(5-bicyclo[2.2.1]hept-2-enylmethyl)-4-(3-nitro-2-pyridyl)-piperazine; treatment of COPD, asthma, urinary incontinence, glaucoma, Alzheimer's (AchE inhibitors), and pain
10/26/2010US7820678 Pyrazinoylguanidine derivatives target the kidney; cardiovascular disease; for treating diseases characterized by too little liquid on mucosal surfaces, increase potency, reduced mucosal absorption, and slow dissociation; long half-life on mucosal surfaces
10/26/2010US7820676 Diketopiperazine salts for drug delivery and related methods
10/26/2010US7820675 Benzofuran compounds
10/26/2010US7820671 Peptidomimetic protease inhibitors
10/26/2010CA2396956C Polypharmacophoric agents
10/26/2010CA2372058C Hemisynthetic method of ecteinascidins and new intermediates
10/21/2010WO2010121003A1 Pyrazine derivatives for optical imaging and therapy
10/21/2010US20100267955 Synthesis of pyrazines including 2,6-diaminopyrazine-1-oxide (dapo) and 2,6-diamino-3,5-dinitropyrazine-1-oxide (llm-105)
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267746 Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
10/21/2010US20100267745 3-Pyridinecarboxamide Derivatives as HDL-Cholesterol Raising Agents
10/21/2010US20100267739 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
10/21/2010US20100267734 N-[(3,5-dichlorophenyl)methyl]-2-(4-methyl-1-piperazinyl)-2-(1-naphthalenyl)ethanamide as ghrelin receptor modulator
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266538 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/20/2010EP2241557A1 Chinoxalin derivatives and use thereof for treating malignant and benign tumour illnesses
10/20/2010CN101863845A Preparation method of 5-methylpyrazine-2-carboxylic acid
10/20/2010CN101863780A Choline salt of hypolipidemic drug and preparation method and pharmaceutical use thereof
10/19/2010US7816530 cis- or trans-4-(4-cyclopropylmethyl-piperazin-1-yl)-cyclohexylamine; antiinflammatory and antiproliferative activity; antiviral and anticarcinogenic agent
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816397 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816358 Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds
10/14/2010WO2010116270A1 Ep2/4 agonists
10/14/2010WO2010115719A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010US20100263062 Methods for screening and compounds that protect against amyloid diseases
10/14/2010US20100261725 Compounds that modulate intracellular calcium
10/14/2010US20100261675 Fungicidal composition containing acid amide derivative
10/14/2010US20100261673 Antibacterial compounds and methods of using same
10/14/2010CA2757138A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/13/2010EP2239262A2 Fused ring heterocycle kinase modulators
10/13/2010EP2238120A2 Improved process for making triphenylboron-pyridine compound
10/13/2010CN1911914B Process for distillatively removing piperazine from an ethylenediamine-piperazine mixture
10/13/2010CN101861307A Certain substituted amides, method of making, and method of use thereof
10/13/2010CN101857575A Industrial preparation method of 5-methylpyrazin-2-amine
10/13/2010CN101857574A Synthesizing method of N-ethyl-2,3-dioxygen piperazine
10/12/2010US7812025 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents
10/12/2010US7812024 such as (4R,11aR)-4-methyl-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one, used for the treatment of obesity, diabetes, atherosclerosis, dyslipidemia, anxiety, depression, psychosis, schizophrenia, sleep, sexual, obsessive compulsive and gastrointestinal disorders
10/12/2010US7811681 Electron transport compound and organic light emitting device comprising the same
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/07/2010WO2010114493A1 Lanthanide metal complexes useful in treating cancer
10/07/2010WO2010113848A1 Isothiourea derivative or isourea derivative having bace1 inhibitory activity
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 187